Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Factor Xa Inhibitor Therapy

Ravindra Sarode, Stephan Maack, Cristina Solomon, Sigurd Knaub, Gita Pezeshki, Sam Schulman

Blood (2023) 142 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2023-188990

Published: 2023

Journal Articles

Bortezomib in Relapsed/Refractory Autoimmune-Mediated Thrombotic Thrombocytopenic Purpura: A Single-Center Case Series and Systematic Review

Nicholas C.J. Lee, Sean Yates, Siayareh Rambally, Ravindra Sarode, Ibrahim F. Ibrahim, Yu-Min Shen, Sandra L. Hofmann, Natalie Bavli

Blood (2022) 140 (Supplement 1): 2693–2694.

https://doi.org/10.1182/blood-2022-165329

Published: 2022

Journal Articles

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Shveta Gupta, MBBS, Ayesha Zia, MD, Ravindra Sarode, MD

Blood (2019) 134 (Supplement_1): 4976.

https://doi.org/10.1182/blood-2019-129118

Published: 2019

Journal Articles

Plasmic Score in Thrombotic Microangiopathy May Not be Discriminatory in Many Instances

Manasa Reddy, MD, Shunsuke Sakurai, BA, So-Youn Park, BSA, Joan Reisch, PhD, Ravindra Sarode, MD

Blood (2018) 132 (Supplement 1): 2440.

https://doi.org/10.1182/blood-2018-99-111416

Published: 2018

Journal Articles

Determinants of Inter-Procedure Interval in Patients with Sickle Cell Anemia Enrolled a Chronic Red Blood Cell Exchange Program

Alecia C. Nero, MD, Theresa Nguyen Kinard, MD, Beverley Adams-Huet, MS, Karen Matevosyan, MD, Ravindra Sarode, MD

Blood (2014) 124 (21): 4284.

https://doi.org/10.1182/blood.V124.21.4284.4284

Published: 2014

Journal Articles

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Ranjit Joseph, MD, Amanda Strickland, James Burner, MD, Sean Yates, MD, William Tharpe, PharmD, Ravindra Sarode, MD

Blood (2014) 124 (21): 1561.

https://doi.org/10.1182/blood.V124.21.1561.1561

Published: 2014

Journal Articles

The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Marcelo Pasquini, Ravindra Sarode, Lawrence Solberg, Jr, Adam E. Haynes, Mark A. Crowther

Blood (2013) 122 (24): 3879–3883.

https://doi.org/10.1182/blood-2013-07-518423

Published: 2013

Includes: Supplemental data

Journal Articles

Comparison Of Thromboelastography (TEG) With Rotational Thromboelastrometry (ROTEM) In Surgical Patients

Theresa Nguyen Kinard, MD, Alana Christie, MS, Philip E. Greilich, MD, Ravindra Sarode, MD

Blood (2013) 122 (21): 3659.

https://doi.org/10.1182/blood.V122.21.3659.3659

Published: 2013

Journal Articles

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Charles Bennett, MD, PhD, MPP, Masanori Matsumoto, MD, Peter Georgantopoulos, MPH, AM, Sony Jacob, MD, Brianne L Dunn, PharmD, Zaina Parvez Qureshi, PhD, MPH, Nicholas Bandarenko, III, MD, Hau C. Kwaan, MD, PhD, Jeffrey Winters, MD, Ravindra Sarode, MD, Joseph E Kiss, MD, Constance Danielson, MD, PhD, Thomas L. Ortel, MD, PhD, Thomas Raife, MD, William F Clark, MD, Gail Rock, PhD, MD, FRCP, X. Long Zheng, MD, PhD, Dennis Raisch, Ph.D., M.S., R.Ph., Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 2203.

https://doi.org/10.1182/blood.V120.21.2203.2203

Published: 2012

Journal Articles

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

Neil Shah, M.D., Karen Matevosyan, MD, James Burner, M.D., Ravindra Sarode, MD

Blood (2011) 118 (21): 2328.

https://doi.org/10.1182/blood.V118.21.2328.2328

Published: 2011

Journal Articles

Heparin-Induced Thrombocytopenia Antibody Is More Common in Patients with Active Bacterial Infections

Melody Smith, MD, Prapti A. Patel, MD, Jonathan E Dowell, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min P Shen, MD

Blood (2011) 118 (21): 4678.

https://doi.org/10.1182/blood.V118.21.4678.4678

Published: 2011

Journal Articles

Initial Management of Suspected Heparin-Induced Thrombocytopenia: Opportunities for Education

Melody Smith, MD, Jonathan E Dowell, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min P Shen, MD

Blood (2011) 118 (21): 4686.

https://doi.org/10.1182/blood.V118.21.4686.4686

Published: 2011

Journal Articles

Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital

Judy Peih-Ying Tsai, MD, Evelyn O. Taiwo, MD, Natalie Cervantes, Guadalupe Jasso, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2010) 116 (21): 3188.

https://doi.org/10.1182/blood.V116.21.3188.3188

Published: 2010

Journal Articles

Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA

Sofyan M. Radaideh, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2010) 116 (21): 1448.

https://doi.org/10.1182/blood.V116.21.1448.1448

Published: 2010

Journal Articles

Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA.

Mohammad Ziari, MD, Catherine Burke, Karen Matevosyan, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2009) 114 (22): 3515.

https://doi.org/10.1182/blood.V114.22.3515.3515

Published: 2009

Journal Articles

Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia.

Prapti A. Patel, MD, Catherine Burke, Karen Matevosyan, MD, Eugene P. Frenkel, MD, Ravindra Sarode, MD, Yu-Min Shen, MD

Blood (2009) 114 (22): 1328.

https://doi.org/10.1182/blood.V114.22.1328.1328

Published: 2009

Journal Articles

Management of Warfarin Associated Intracranial Hemorrhage with a 3-Factor Prothrombin Complex Concentrate and Low Dose Recombinant Factor VIIa.

Karén Matevosyan, MD, Christopher Madden, MD, Fleur M Aung, MD, David P Chason, MD, Garry Arbique, PhD, Jeffrey Guild, PhD, Shahid Shafi, MD, Ravindra Sarode, MD

Blood (2008) 112 (11): 3397.

https://doi.org/10.1182/blood.V112.11.3397.3397

Published: 2008

Journal Articles

Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Blood (2008) 112 (11): 2293.

https://doi.org/10.1182/blood.V112.11.2293.2293

Published: 2008

Journal Articles

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Anaadriana Zakarija, MD, Hau C. Kwaan, MD PhD, Nicholas Banderanko, MD, Dilip K. Pandey, MD PhD, John F. Cursio, MS, Ivy M. Weiss, BA, Thanh Ha Luu, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD PhD, Thomas J. Raife, MD, Ravindra Sarode, MD, Charles L. Bennett, MD PhD MPP

Blood (2007) 110 (11): 1320.

https://doi.org/10.1182/blood.V110.11.1320.1320

Published: 2007

Journal Articles

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Charles L. Bennett, MD, PhD, MPP, Thanh Ha Luu, BA, Anaadriana Zakarija, MD, Hau C. Kwaan, MD, PhD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, John F. Cursio, MS, June M. McKoy, MD, JD, MPH, Charlie Buffie, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD, Ravindra Sarode, MD, X. Long Zheng, MD, PhD, Thomas J. Raife, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Gail A. Rock, MD, PhD

Blood (2007) 110 (11): 2088.

https://doi.org/10.1182/blood.V110.11.2088.2088

Published: 2007

NARROW

Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Factor Xa Inhibitor Therapy

Bortezomib in Relapsed/Refractory Autoimmune-Mediated Thrombotic Thrombocytopenic Purpura: A Single-Center Case Series and Systematic Review

International Survey for Strategies Used for Oral Anticoagulation Reversal in Children

Plasmic Score in Thrombotic Microangiopathy May Not be Discriminatory in Many Instances

Determinants of Inter-Procedure Interval in Patients with Sickle Cell Anemia Enrolled a Chronic Red Blood Cell Exchange Program

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

The ASH Choosing Wisely ® campaign: five hematologic tests and treatments to question

Comparison Of Thromboelastography (TEG) With Rotational Thromboelastrometry (ROTEM) In Surgical Patients

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

Heparin-Induced Thrombocytopenia Antibody Is More Common in Patients with Active Bacterial Infections

Initial Management of Suspected Heparin-Induced Thrombocytopenia: Opportunities for Education

Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital

Incidence of Isolated Heparin-Induced Thrombocytopenia and the Risk of Developing Subsequent Thrombosis Using the New IgG Specific Anti-PF4/Heparin ELISA

Optical Density of 1.0 Is a Better Cutoff for Positive HIT Ab ELISA.

Low Risk 4T Score Can Rule out Heparin-Induced Thrombocytopenia.

Management of Warfarin Associated Intracranial Hemorrhage with a 3-Factor Prothrombin Complex Concentrate and Low Dose Recombinant Factor VIIa.

Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only